Somaxon Pharmaceuticals, Inc. (NASDAQ:SOMX)
|
3.38 -0.30 (-8.15%) 2:57EST Delayed |
|
|
|
- Compare SOMX with:
- View: Line | Candlestick
Company Profile
Somaxon Pharmaceuticals, Inc.
3721 Valley Centre Drive
San Diego, CA 92130
United States - Map
Phone: +858 5093670
Fax: +858 5091589
Website: www.somaxon.com
State of incorporation: Delaware
CEO: Richard W. Pascoe
Employees: 5
Sector: Healthcare
Industry Group: Drugs
Industry: Drug Manufacturers - Other
A specialty pharmaceutical company
Somaxon Pharmaceuticals, Inc. is a specialty pharmaceutical company focused on the in-licensing, development and commercialization of late-stage product candidates for the treatment of diseases and disorders in the central nervous system therapeutic area.
Recent news for SOMX
-
Somaxon Pharmaceuticals Inc. is Today's Focus Stock on MicroStockProfit.com
GlobeNewswire - Jul 21 at 6:50AM (EST)
-
Indie Research - Jul 16 at 11:08AM (EST)
-
Somaxon shares up on deal to promote insomnia drug
MarketWatch - Jul 15 at 12:37PM (EST)
-
InPlay: Somaxon Pharma establishes Silenor commercial team
Briefing.com - Jul 14 at 4:07PM (EST)
-
Somaxon Pharmaceuticals Establishes Silenor Commercial Team
Business Wire - Jul 14 at 4:05PM (EST)
-
Analysts, Announcements Fuel Continued Biotech Rally
Indie Research - Jul 14 at 12:28PM (EST)
-
Biotech Stock Mailbag: Somaxon
TheStreet.com - Jul 09 at 7:00AM (EST)
-
TheStreet.com - Jun 28 at 9:39AM (EST)
-
Business Wire - Jun 28 at 8:05AM (EST)
-
Biodel, Arena Pharma: Volume Movers
TheStreet.com - Jun 28 at 8:00AM (EST)
Member sentiment (?) Neutral
Recent opinions on SOMX
-
Stocks to watch this week .....
Jun 13 at 4:03PM (EST) (By MadMoney)
-
Hana Biosciences: The Perfect ASCO Conference Investment Opportunity
Jun 03 at 3:00AM (EST) (By StocksHaven)
No members own SOMX